NCT04310007 2026-05-29Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting117 enrolled